Donor T Cells Administered Over HLA Class II Barriers Mediate Antitumor Immunity without Broad Off-Target Toxicity in a NOD/Scid Mouse Model of Acute Leukemia

Author(s):
Stevanovic, S.; Nijmeijer, B.A.; Schie, M.L.J. van; Salvatori, D.C.F.; Maas, S.; Griffioen, M. (0000-0002-3001-4441); Falkenburg, J.H.F.
Published
2013
Publication type
Article / Letter to editor
Graft-versus-leukemia effectXenogeneic graft-versus-host diseaseDonor lymphocyte infusionHLA-mismatched allogeneic stem cell transplantation
Date issued
2013-06-30
Language
English
Is part of
Biology of Blood and Marrow Transplantation (2013), Vol. 19, no. 6, p. 867-875
hdl
1887/102513
doi
10.1016/j.bbmt.2013.03.003